Effects of long-term supplementation with omega-3 fatty acids on longitudinal changes in bone mass and microstructure in mice

Journal of Nutritional Biochemistry

Volumn 22, Issue 7, 2011, Pages 665-672

  Bonnet, Nicolas ^a   Ferrari, Serge L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bone mineral density; Leptin; Long term; Microarchitecture; Omega 3; Strength

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LEPTIN;

ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE REMODELING; BONE STRENGTH; BONE STRUCTURE; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; DIET SUPPLEMENTATION; FEMALE; FEMUR; MORPHOMETRICS; MOUSE; NONHUMAN; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE DENSITY; DIETARY FATS, UNSATURATED; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MICE; OSTEOCALCIN;

MUS;

EID: 79958780847     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.05.006     Document Type: Article

References (59)

1. Rossignol M., Moride Y., Perreault S., Boivin J.F., Ste-Marie L.G., Robitaille Y., et al. recommendations for the prevention of osteoporosis and fragility fractures. Int J Technol Assess Health Care 2002, 18:597-610.
2. Abellan van Kan G., Gambassi G., de Groot L.C., Andrieu S., Cederholm T., André E., et al. Nutrition and aging, the Carla Workshop. J Nutr Health Aging 2008, 12:355-364.
3. Ohnell O., Gullberg B., Allander E., Kanis J.A. The apparent incidence of hip fracture in Europe: a study of national register sources MEDOS Study Group. Osteoporos Int 1992, 2:298-302.
4. Kannus P., Parkkari J., Sievänen H., Heinonen A., Vuori I., Järvinen M. Epidemiology of hip fractures. Bone 1996, 18:57S-63S.
5. Willett W.C., Sacks F., Trichopoulou A., Drescher G., Ferro-Luzzi A., Helsing E., et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995, 61:1402S-1406S.
6. Kontogianni M.D., Melistas L., Yannakoulia M., Malagaris I., Panagiotakos D.B., Yiannakouris N. Association between dietary patterns and indices of bone mass in a sample of Mediterranean women. Nutrition 2009, 25:165-171.
7. Puel C., Coxam V., Davicco M.J. Mediterranean diet and osteoporosis prevention. Med Sci 2007, 23:756-760.
8. Fernandes G., Bhattacharya A., Rahman M., Zaman K., Banu J. Effects of n-3 fatty acids on autoimmunity and osteoporosis. Front Biosci 2008, 13:4015-4020.
9. Lavie C.J., Milani R.V., Mehra M.R., Ventura H.O. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 2009, 54:585-594.
10. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991, 54:438-463.
11. Watkins B.A., Li Y., Lippman H.E., Seifert M.F. Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood) 2001, 226:485-497.
12. Weiss L.A., Barrett-Connor E., von Mühlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr 2005, 81:934-938.
13. Poulsen R.C., Moughan P.J., Kruger M.C. Long-chain polyunsaturated fatty acids and the regulation of bone metabolism. Exp Biol Med (Maywood) 2007, 232:1275-1288.
14. Sun D., Krishnan A., Zaman K., Lawrence R., Bhattacharya A., Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18:1206-1216.
15. Fernandes G., Lawrence R., Sun D. Protective role of n-3 lipids and soy protein in osteoporosis. Prostaglandins Leukot Essent Fatty Acids 2003, 68:361-372.
16. Poulsen R.C., Wolber F.M., Moughan P.J., Kruger M.C. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. Prostaglandins Other Lipid Mediat 2008, 85:42-48.
17. Bhattacharya A., Rahman M., Banu J., Lawrence R.A., McGuff H.S., Garrett I.R., et al. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids. J Am Coll Nutr 2005, 24:200-209.
18. Coetzee M., Haag M., Joubert A.M., Kruger M.C. Effects of arachidonic acid, docosahexaenoic acid and prostaglandin E(2) on cell proliferation and morphology of MG-63 and MC3T3-E1 osteoblast-like cells. Prostaglandins Leukot Essent Fatty Acids 2007, 76:35-45.
19. Frøyland L., Madsen L., Vaagenes H., Totland G.K., Auwerx J., Kryvi H., et al. Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. J Lipid Res 1997, 38:1851-1858.
20. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2:35-43.
21. Rahman M.M., Bhattacharya A., Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol 2008, 214:201-209.
22. Kruger M.C., Horrobin D.F. Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res 1997, 36:131-151.
23. Claassen N., Coetzer H., Steinmann C.M., Kruger M.C. The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. Prostaglandins Leukot Essent Fatty Acids 1995, 53:13-19.
24. Kruger M.C., Schollum L.M. Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability?. Prostaglandins Leukot Essent Fatty Acids 2005, 73:327-334.
25. Poulsen R.C., Firth E.C., Rogers C.W., Moughan P.J., Kruger M.C. Specific effects of gamma-linolenic, eicosapentaenoic, and docosahexaenoic ethyl esters on bone post-ovariectomy in rats. Calcif Tissue Int 2007, 81:459-471.
26. Beamer W.G., Donahue L.R., Rosen C.J., Baylink D.J. Genetic variability in adult bone density among inbred strains of mice. Bone 1996, 18:397-403.
27. Glatt V., Canalis E., Stadmeyer L., Bouxsein M.L. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 2007, 22:1197-1207.
28. Boutroy S., Bouxsein M.L., Munoz F., Delmas P.D. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab 2005, 90:6508-6515.
29. Ferguson V.L., Ayers R.A., Bateman T.A., Simske S.J. Bone development and age-related bone loss in male C57BL/6J mice. Bone 2003, 33:387-398.
30. Somerville J.M., Aspden R.M., Armour K.E., Armour K.J., Reid D.M. Growth of C57BL/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int 2004, 74:469-475.
31. Iida-Klein A., Lu S.S., Yokoyama K., Dempster D.W., Nieves J.W., Lindsay R. Precision, accuracy, and reproducibility of dual X-ray absorptiometry measurements in mice in vivo. J Clin Densitom 2003, 6:25-33.
32. Waarsing J.H., Day J.S., van der Linden J.C., Ederveen A.G., Spanjers C., De Clerck N., et al. Detecting and tracking local changes in the tibiae of individual rats: a novel method to analyse longitudinal in vivo micro-CT data. Bone 2004, 34:163-169.
33. Waarsing J.H., Day J.S., Weinans H. An automatic algorithm to segment 3D microCT scans of bone 2002.
34. Hildebrand T., Ruegsegger P. A new method for the model-independent assessment of thickness in the three-dimensional images. J Microsc 1997, 185:67-75.
35. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
36. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14:595-608.
37. Halloran B.P., Ferguson V.L., Simske S.J., Burghardt A., Venton L.L., Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J Bone Miner Res 2002, 17:1044-1050.
38. Tommasini S.M., Morgan T.G., van der Meulen M.C.h., Jepsen K.J. Genetic variation in structure-function relationships for the inbred mouse lumbar vertebral body. J Bone Miner Res 2005, 20:817-827.
39. Hamrick M.W., Pennington C., Newton D., Xie D., Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004, 34:376-383.
40. Zwart S.R., Pierson D., Mehta S., Gonda S., Smith S.M.. Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-kappaB activation: from cells to bed rest to astronauts. J Bone Miner Res 2010, 25:1049-1057.
41. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., Kondo H., Richards W.G., Bannon T.W., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
42. Kang J.X., Weylandt K.H. Modulation of inflammatory cytokines by omega-3 fatty acids. Subcell Biochem 2008, 49:133-143.
43. Seeman E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 2003, 14:S2-S8.
44. Reinwald S., Li Y., Moriguchi T., Salem N., Watkins B.A. Repletion with (n-3) fatty acids reverses bone structural deficits in (n-3)-deficient rats. J Nutr 2004, 134:388-394.
45. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140:1630-1638.
46. Thomas T. Leptin: a potential mediator for protective effects of fat mass on bone tissue. Joint Bone Spine 2003, 70:18-21.
47. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., Ke H., Swick A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000, 92:73-78.
48. Cornish J., Callon K.E., Bava U., Lin C., Naot D., Hill B.L., Grey A.B., Broom N., Myers D.E., et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol Invest 2002, 175:405-415.
49. Drevon C.A. Fatty acids and expression of adipokines. Biochim Biophys Acta 2005, 1740:287-292.
50. Takeda S. Hormones and osteoporosis update. Regulation of bone remodeling by adipokines. Clin Calcium 2009, 19:1009-1014.
51. 2 biosynthesis, tissue IGF-I levels, and bone morphometry in chicks. J Bone Miner Res 1996, 11:1321-1332.
52. Mazzuco H., McMurtry J.P., Kuo A.Y., Hester P.Y. The effect of pre- and postmolt diets high in n-3 fatty acids and molt programs on skeletal integrity and insulin-like growth factor-I of White Leghorns. Poult Sci 2005, 84:1735-1749.
53. Bourrin S., Ammann P., Bonjour J.P., Rizzoli R. Dietary protein restriction lowers plasma insulin-like growth factor I (IGF-I), impairs cortical bone formation, and induces osteoblastic resistance to IGF-I in adult female rats. Endocrinology 2000, 141:3149-3155.
54. Bateman T.A., Zimmerman R.J., Ayers R.A., Ferguson V.L., Chapes S.K., Simske S.J. Histomorphometric, physical, and mechanical effects of spaceflight and insulin-like growth factor-I on rat long bones. Bone 1998, 23:527-535.
55. Iwamoto J., Yeh J.K., Takeda T., Ichimura S., Sato Y. Comparative effects of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats. Bone 2003, 33:557-566.
56. Matsushita H., Barrios J.A., Shea J.E., Miller S.C. Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab 2008, 26:241-247.
57. Poulsen R.C., Kruger M.C. Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 2006, 75:419-427.
58. Micallef M., Munro I., Phang M., Garg M. Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 2009, 19:1-5.
59. Yamagishi K., Iso H., Date C., Fukui M., Wakai K., Kikuchi S., et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008, 52:988-996.